Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Ejhaem|October 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocolNeil D Palmisiano, Ju-Whei Lee, David F Claxton, et al.
Blood Advances|April 2, 2024
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significanceMarissa Li, Anmol Baranwal, Mark Gurney, et al.
American Journal of Hematology|April 12, 2021
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive casesNaseema Gangat, Paola Guglielmelli, Natasha Szuber, et al.
British Journal of Haematology|February 4, 2024
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agentsIsla M Johnson, Omer Karrar, Masooma Rana, et al.
Leukemia & Lymphoma|November 6, 2024
Clinical outcomes of patients diagnosed with <i>SETBP1</i> mutated myeloid neoplasmsYazan Jabban, Mahmoud Yacout, Anmol Baranwal, et al.
Transplantation and Cellular Therapy|April 8, 2021
Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALLZaid H Abdel Rahman, Michael G Heckman, Kevin Miller, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2019
Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysisRong He, Daniel J Devine, Zheng Jin Tu, et al.
Blood Neoplasia|April 6, 2026
Treatment-specific prognostic performance of ELN 2022, ELN 2024, and Beat AML 2024: a real-world AML validation studyTariq Kewan, Oudai Alkabbani, Hadil Zureigat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 9, 2019
Correction to: Hybridization capture-based next-generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysisRong He, Daniel J Devine, Zheng Jin Tu, et al.
British Journal of Haematology|October 26, 2021
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemiaZaid H Abdel Rahman, Ricardo D Parrondo, Michael G Heckman, et al.
Pageof 5